手术切除与5%氟尿嘧啶及光动力疗法治疗鲍恩病的多中心随机对照试验
这项多中心非劣效性随机试验纳入250例组织学证实的鲍恩病患者,比较手术切除、5%氟尿嘧啶乳膏和MAL-PDT的12个月持续清除率。手术切除组持续清除率为97.4%,5-氟尿嘧啶组为85.7%,MAL-PDT组为82.1%。基于预设22%非劣效界值,5-氟尿嘧啶对手术切除非劣效且美容效果更好,MAL-PDT对手术切除的非劣效性无法得出结论。
要点
- 5-氟尿嘧啶组12个月持续清除率85.7%,对手术切除(97.4%)非劣效。
- MAL-PDT组持续清除率82.1%,对手术切除的非劣效性无法得出结论。
- 两种无创治疗的美容效果良好或极好的比例显著高于手术切除。
核心结论
- 基于预设22%非劣效界值,5-氟尿嘧啶对手术切除非劣效且美容效果更好。
- MAL-PDT对手术切除的非劣效性无法得出结论。
- 因此,在鲍恩病治疗中,5-氟尿嘧啶应优先于手术切除和MAL-PDT。
研究设计与样本
- 多中心非劣效性随机对照试验,纳入组织学证实的4-40 mm鲍恩病患者250例。
- 患者随机分配至手术切除(5 mm边缘)、5% 5-氟尿嘧啶乳膏每日两次共4周,或MAL-PDT两次(间隔1周)。
- 主要结局为治疗后12个月持续清除的比例,非劣效界值为22%。
主要发现
- 12个月持续清除率:手术切除组97.4%(75/77),5-氟尿嘧啶组85.7%(66/77),MAL-PDT组82.1%(64/78)。
- 5-氟尿嘧啶 versus 手术切除的绝对差异为-11.7%(95% CI -18.9 to -4.5;P = .0049)。
- MAL-PDT versus 手术切除的绝对差异为-15.4%(95% CI -23.1 to -7.6;P = .00078)。
- 两种无创治疗导致良好或极好美容结局的比例显著高于手术切除。
关键数值与推荐
- 非劣效界值:22%。
- 5-氟尿嘧啶方案:5%乳膏每日两次,共4周。
- MAL-PDT方案:2次 sessions,间隔1周。
- 手术切除边缘:5 mm。
临床怎么用
- 在鲍恩病治疗中,5-氟尿嘧啶应优先于手术切除和MAL-PDT。
- MAL-PDT对手术切除的非劣效性无法得出结论。
- 两种无创治疗的美容效果良好或极好的比例显著高于手术切除。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomized controlled trials comparing the effectiveness of 5-fluorouracil cream, methylaminolevulinate photodynamic therapy (MAL-PDT) and surgical excision in patients with Bowen's disease are lacking. METHODS: In this multicenter noninferiority trial, patients with a histologically proven Bowen's disease of 4-40 mm were randomly assigned to excision with 5 mm margin, 5% 5-fluorouracil cream twice daily for 4 weeks, or 2 sessions of MAL-PDT with 1 week interval. The primary outcome was the proportion of patients with sustained clearance at 12 months after treatment. A noninferiority margin of 22% was used. RESULTS: Between May 2019 and January 2021, 250 patients were randomized. The proportion of patients with sustained clearance was 97.4% (75/77) after excision, 85.7% (66/77) after 5-fluorouracil, and 82.1% (64/78) after MAL-PDT. Absolute differences were -11.7% (95% CI -18.9 to -4.5; P = .0049) for 5-fluorouracil versus excision and -15.4% (95% CI -23.1 to -7.6; P = .00078) for MAL-PDT versus excision. Both noninvasive treatments significantly more often led to good or excellent cosmetic outcome. CONCLUSIONS: Based on our predefined noninferiority margin of 22%, 5-fluorourcail is noninferior to excision and associated with better cosmetic outcome. For MAL-PDT noninferiority to excision cannot be concluded. Therefore, 5-fluorouracil should be preferred over excision and MAL-PDT in treatment of Bowen's disease.
引用
- Ahmady S, Nelemans PJ, Kelleners-Smeets NWJ, et al. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial. J Am Acad Dermatol. 2023. PMID: 37666424. doi:10.1016/j.jaad.2023.08.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。